abstract |
The invention relates to the novel base-substituted benzylamine analogs of general formula (I), wherein A represents P 2 -P 1 with P 1 ═(A) and P 2 ═(B), for use as coagulation factor Xa inhibitors. The invention also relates to the production and use of said analogs in the therapy and prophylaxis of cardiovascular diseases and thromboembolic events. |